Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of reduced-dose oral iron for iron deficiency anaemia in inflammatory bowel disease
2018-002982-20Phase 4Unknown
- Sponsor
- Royal Liverpool University Hospital
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ferrous fumarate in iron deficiency anemia (IDA) and inflammatory bowel disease (IBD), sponsored by Royal Liverpool University Hospital. Primary endpoint: Feasibility of a larger randomized trial. Status: unknown.
02
Drugs
ferrous fumarate
03
Conditions
iron deficiency anemia (IDA)inflammatory bowel disease (IBD)
Beyond the preview
Go deeper on 2018-002982-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002982-20.